---
title: "Mapping SARS-CoV-2 Nucleocapsid Escape Sites That Threaten Rapid Antigen Tests"
id: "pubmed-42872825"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42872825"
content_type: "clinical_feed_article"
specialty: "Critical Care"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42872825/"
doi: "10.1128/jvi.01001-26"
published_at: "2026-11-17T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Mapping SARS-CoV-2 Nucleocapsid Escape Sites That Threaten Rapid Antigen Tests
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42872825
- **Specialty:** [Critical Care](https://medichelpline.com/clinical-feed/critical-care.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42872825/)
- **DOI:** [10.1128/jvi.01001-26](https://doi.org/10.1128%2Fjvi.01001-26)
- **Published At:** 2026-11-17T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Investigators used **deep mutational scanning** (DMS) to map escape mutations across 82 antibodies used in 43 commercially available rapid antigen tests, creating a comprehensive escape dataset. - The team identified that most antibodies recognize conformational epitopes rather than linear motifs, which affects vulnerability to single amino-acid substitutions. - Antibody binding localized primarily to two structural regions: 47 antibodies (57%) to the **RNA-binding domain** and 23 (28%) to the **dimerization domain** of the nucleocapsid protein. - Principal component analysis and clustering revealed distinct escape phenotypes; some antibodies shared escape patterns outside their predicted structural epitopes. - The authors observed an industry shift from IgG to IgM antibody usage over the pandemic period, and this shift coincided with changes in epitope subclass prevalence. - Paired capture-detection antibody analysis showed a preference for targeting the same structural domain in 20 of 33 pairs (61%), implying tests often use orthogonal but proximal sites. - The dataset allows identification of specific tests and antibodies at risk for mutation-driven loss of binding; the authors noted this resource can prioritize candidates for follow-up **performance testing**. - The report frames the resource as a tool to guide the design of diagnostics that are more resilient to viral evolution and applicable to other respiratory viruses, while also indicating further empirical performance validation is needed.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42872825/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42872825%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42872825/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42872825/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42872825/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42872825/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42872825/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42872825/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42872825%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42872825%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42872825/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42872825/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42872825/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42872825/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Atypon full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--journals.asm.org-pb-assets-pubmed-pubmed_ASMJ_OA.png) Atypon ](https://journals.asm.org/doi/10.1128/jvi.01001-26?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed "See full text options at Atypon") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42872825/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42872825/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42872825/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42872825/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42872825/#conflict-of-interest) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42872825/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42872825/#substances) * [Related information](https://pubmed.ncbi.nlm.nih.gov/42872825/#related-links) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42872825/#linkout) Title & authors Abstract Conflict of interest statement MeSH terms Substances Related information LinkOut - more resources J Virol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22J+Virol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J+Virol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42872825/) . 2026 Nov 17;100(11):e0100126. doi: 10.1128/jvi.01001-26. Epub 2026 Oct 14. # Variant escape site mapping and characterization of SARS-CoV-2 nucleocapsid rapid antigen test antibodies [Alasdair D Keith](https://pubmed.ncbi.nlm.nih.gov/?term=Keith+AD&cauthor_id=42872825)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#full-view-affiliation-1 "Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA."), [Meredith M Keen](https://pubmed.ncbi.nlm.nih.gov/?term=Keen+MM&cauthor_id=42872825)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#full-view-affiliation-1 "Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA."), [Filipp Frank](https://pubmed.ncbi.nlm.nih.gov/?term=Frank+F&cauthor_id=42872825)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#full-view-affiliation-1 "Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA."), [Wilbur A Lam](https://pubmed.ncbi.nlm.nih.gov/?term=Lam+WA&cauthor_id=42872825)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#full-view-affiliation-2 "The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Emory University, Atlanta, Georgia, USA.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#full-view-affiliation-3 "Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#full-view-affiliation-4 "Wallace H. Coulter Department of Biomedical Engineering, Emory University, Georgia Institute of Technology, Atlanta, Georgia, USA.")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#full-view-affiliation-5 "Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia, USA."), [Morgan Greenleaf](https://pubmed.ncbi.nlm.nih.gov/?term=Greenleaf+M&cauthor_id=42872825)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#full-view-affiliation-2 "The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Emory University, Atlanta, Georgia, USA."), [Eric A Ortlund](https://pubmed.ncbi.nlm.nih.gov/?term=Ortlund+EA&cauthor_id=42872825)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#full-view-affiliation-1 "Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#full-view-affiliation-2 "The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Emory University, Atlanta, Georgia, USA.") Affiliations Expand ### Affiliations * 1 Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA. * 2 The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Emory University, Atlanta, Georgia, USA. * 3 Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA. * 4 Wallace H. Coulter Department of Biomedical Engineering, Emory University, Georgia Institute of Technology, Atlanta, Georgia, USA. * 5 Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia, USA. * PMID: **42872825** * DOI: [ 10.1128/jvi.01001-26 ](https://doi.org/10.1128/jvi.01001-26) Free article Item in Clipboard # Variant escape site mapping and characterization of SARS-CoV-2 nucleocapsid rapid antigen test antibodies Alasdair D Keith et al. J Virol. 2026. Free article Show details Display options Display options Format Abstract PubMed PMID J Virol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22J+Virol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J+Virol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42872825/) . 2026 Nov 17;100(11):e0100126. doi: 10.1128/jvi.01001-26. Epub 2026 Oct 14. ### Authors [Alasdair D Keith](https://pubmed.ncbi.nlm.nih.gov/?term=Keith+AD&cauthor_id=42872825)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#short-view-affiliation-1 "Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA."), [Meredith M Keen](https://pubmed.ncbi.nlm.nih.gov/?term=Keen+MM&cauthor_id=42872825)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#short-view-affiliation-1 "Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA."), [Filipp Frank](https://pubmed.ncbi.nlm.nih.gov/?term=Frank+F&cauthor_id=42872825)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#short-view-affiliation-1 "Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA."), [Wilbur A Lam](https://pubmed.ncbi.nlm.nih.gov/?term=Lam+WA&cauthor_id=42872825)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#short-view-affiliation-2 "The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Emory University, Atlanta, Georgia, USA.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#short-view-affiliation-3 "Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#short-view-affiliation-4 "Wallace H. Coulter Department of Biomedical Engineering, Emory University, Georgia Institute of Technology, Atlanta, Georgia, USA.")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#short-view-affiliation-5 "Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia, USA."), [Morgan Greenleaf](https://pubmed.ncbi.nlm.nih.gov/?term=Greenleaf+M&cauthor_id=42872825)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#short-view-affiliation-2 "The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Emory University, Atlanta, Georgia, USA."), [Eric A Ortlund](https://pubmed.ncbi.nlm.nih.gov/?term=Ortlund+EA&cauthor_id=42872825)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#short-view-affiliation-1 "Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42872825/#short-view-affiliation-2 "The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Emory University, Atlanta, Georgia, USA.") ### Affiliations * 1 Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA. * 2 The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Emory University, Atlanta, Georgia, USA. * 3 Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA. * 4 Wallace H. Coulter Department of Biomedical Engineering, Emory University, Georgia Institute of Technology, Atlanta, Georgia, USA. * 5 Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia, USA. * PMID: **42872825** * DOI: [ 10.1128/jvi.01001-26 ](https://doi.org/10.1128/jvi.01001-26) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Rapid antigen tests (RATs) were a critical tool for diagnosing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the height of the pandemic, but their performance depends on antibodies that remain robust to viral evolution. Since most commercial RATs target the viral nucleocapsid protein, mutations in this domain can compromise binding and test performance. To systematically define this risk, we used deep mutational scanning (DMS) to map escape mutations for 82 antibodies across 43 commercially available tests, generating the most comprehensive escape database of SARS-CoV-2 viral mutations to date. Most antibodies target conformational epitopes, with 47 (57%) mapping to the RNA-binding domain and 23 (28%) to the dimerization domain. Principal component analysis and clustering revealed escape phenotypes, including shared features outside of predicted epitopes. As the pandemic proceeded, we noted a change in industry preference from IgG to IgM-type antibodies, which was associated with changes to epitope sub-class prevalence. Analysis of paired capture-detection antibodies revealed a preference for targeting the same structural domain (20/33 or 61%), indicating a slight preference for test antibodies to hit orthogonal yet proximal sites. Together, the results establish a comprehensive resource for understanding how SARS-CoV-2 nucleocapsid protein mutations affect antibody binding and the phenotypes that underlie RAT antibody selection. This resource and approach can help prioritize antibodies for follow-up performance testing and support the design of more mutation-resilient diagnostics.IMPORTANCEIt is critical during a pandemic for diagnostic tests to be accurate and for the false negative rate to be kept low. The rapidly changing nature of SARS-CoV-2 exposed a weakness with using rapid antigen tests to diagnose infection, as mutations to the viral nucleocapsid protein can cause the virus to evade detection. In this work, we systematically tested the robustness of 82 antibodies from 43 separate commercially available tests by deliberately mutating the nucleocapsid protein and investigating which changes caused weakened binding to the test antibodies. In addition to determining which specific tests were at risk from certain mutations, we collated our datasets into a meta-analysis, allowing us to identify some best practices for designing robust tests. We, therefore, expect that this resource will support the design of more mutation-resilient diagnostics, whether for future variants of SARS-CoV-2 or in applying these principles to other respiratory viruses, such as influenza virus. **Keywords:** SARS-CoV-2; deep mutational scanning; nucleocapsid; rapid antigen test diagnostics. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement The authors declare no conflict of interest. ## MeSH terms * Antibodies, Viral* / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Antibodies%2C+Viral%2Fimmunology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Antibodies%2C+Viral) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42872825/) * Antigens, Viral / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Antigens%2C+Viral%2Fimmunology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Antigens%2C+Viral) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42872825/) * COVID-19 Serological Testing* / methods Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22COVID-19+Serological+Testing%2Fmethods%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=COVID-19+Serological+Testing) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42872825/) * COVID-19* / diagnosis Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22COVID-19%2Fdiagnosis%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=COVID-19) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42872825/) * COVID-19* / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22COVID-19%2Fimmunology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=COVID-19) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42872825/) * COVID-19* / virology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22COVID-19%2Fvirology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=COVID-19) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42872825/) * Coronavirus Nucleocapsid Proteins* / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Coronavirus+Nucleocapsid+Proteins%2Fgenetics%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Coronavirus+Nucleocapsid+Proteins) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42872825/) * Coronavirus Nucleocapsid Proteins* / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Coronavirus+Nucleocapsid+Proteins%2Fimmunology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Coronavirus+Nucleocapsid+Proteins) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42872825/) * Epitope Mapping Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Epitope+Mapping%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Epitope+Mapping) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42872825/) * Epitopes / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Epitopes%2Fgenetics%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Epitopes) * [ A
## Related Clinical Research

- [Epidemiologic Variability and Clinical Severity of Pediatric Influenza Across 11 Seasons](https://medichelpline.com/clinical-feed/pubmed-43035904.md) (DOI: 10.1097/INF.0000000000005470)
- [Mobile-app cohort event monitoring of COVID-19 vaccines (SafeVac2.0)](https://medichelpline.com/clinical-feed/pubmed-42843285.md) (DOI: 10.1016/j.vaccine.2026.129219)
- [CDC: About 1 in 10 U.S. Adults Used GLP-1 Medications in 2025; Industry Demands WHO Audit](https://medichelpline.com/clinical-feed/stat-news-7-stat-pharmalittle-we-re-reading-about-glp-1-use-covid-19-vaccine-investment.md)
- [Maternal and Early-Life Obesity Impairs CD4+ T Cell Programming and Vaccine Responses](https://medichelpline.com/clinical-feed/nature-immunology-1-maternal-and-early-life-obesity-programs-cd4-t-cell-fate-to-impair-vaccine.md)
- [Palmar lactic acid links to reduced hand scaling and greater in vitro pathogen inactivation](https://medichelpline.com/clinical-feed/plos-one-12-associations-of-palmar-surface-lactic-acid-with-hand-scaling-and-in-vitro.md)

## Navigation
- [← Back to Critical Care Feed](https://medichelpline.com/clinical-feed/critical-care.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.